Human Pancreatic Microvascular Endothelial Cells

Cat.No.: CSC-C4366X

Species: Human

Source: Pancreas

Cell Type: Endothelial Cell; Microvascular Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C4366X
Description
Human Pancreatic Microvascular Endothelial Cells from Creative Bioarray are isolated from human pancreatic tissue. Human Pancreatic Microvascular Endothelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based solution for 2 min and incubated in Creative Bioarray’ Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells at passage 3 are detached from flasks and immediately cryopreserved in vails. Each vial contains at least 0.5×10^6 cells per ml. The method we use to isolate endothelial cells was developed based on a combination of established and our proprietary methods. These cells are pre-coated with PECAM-1 antibody, following the application of magnetic beads pre-coated with secondary antibody.
Species
Human
Source
Pancreas
Cell Type
Endothelial Cell; Microvascular Cell
Disease
Normal
Quality Control
Human Pancreatic Microvascular Endothelial Cells from Creative Bioarray display typical cobblestone with large dark nuclei appearance under light microscopy. Cells are tested for expression of endothelial cell marker using antibody, CD31 (Catalog No. 550389, BD; CD31/PECAM-1 PE-conjugated Antibody, Catalog No. FAB3567P, R&D) or VE-Cadherin (FITC-VE-cadherin Catalog No. 560411, BD) by immunofluorescence staining or FACS.  All cells test negative for mycoplasma, bacteria, yeast, and fungi. HIV-1, hepatitis B and hepatitis C are not detected for all donors and/or cell lots. Per request, a Certificate of Analysis will be provided for each cell lot purchased. Cells can be expanded for 3-5 passages under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Live cell shipment is also available on request. Never can cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human Pancreatic Microvascular Endothelial Cells (HPMECs) are primary endothelial cells derived from human pancreatic microvasculature. They offer an in vitro model system that is physiologically relevant for studying pancreatic vascular biology and endothelial cell function. These cells contribute to homeostasis of pancreatic tissue and regulate nutrient delivery, barrier function and paracrine support of the pancreatic microenvironment.

HPMECs have a classic cobblestone endothelial cell morphology and under normal culture conditions they exhibit tight junctions and grow to confluency as a monolayer. They are positive for endothelial cell markers including CD31 (PECAM-1), VE-cadherin, von Willebrand factor (vWF) and endothelial nitric oxide synthase (eNOS). HPMECs are responsive to angiogenic and inflammatory cues and possess regulated permeability and nitric oxide-mediated responses.

HPMECs have been utilized in studies to model pancreatic microcirculation, angiogenesis, endothelial cell dysfunction and responses to metabolic and inflammatory stimuli involved in diseases such as diabetes mellitus and pancreatitis. These models are particularly useful to study endothelial-islet cell interactions, vascular remodeling, pancreatic inflammation and injury. HPMECs can also be used to screen vascular-targeted and/or anti-inflammatory therapies.

PDAC EVs are Readily Imported by Endothelial Cells in vitro

Pancreatic ductal adenocarcinoma (PDAC) is hypovascular with collapsed vessels that limit immunosurveillance and promote metastasis; antiangiogenic therapies have failed. Finan et al. investigated whether the RNA-binding protein HuR in cancer cells reshapes the tumor microenvironment by regulating extracellular vesicle (EV) cargo that signals to endothelial cells.

To assess whether endothelial cells import human PDAC EVs, they optimized in vitro EV import studies using the lipophilic dye PKH67. Endothelial cells treated with PKH67-labeled EVs showed significant EV import by 4 hours, after which the lipid signal became diffuse as lipids were recycled (Fig. 1A). EV import was concentration-dependent, so subsequent studies used the concentration released by PDAC cells over 48 hours (~300 EVs/cell; Fig. 1B). Control experiments confirmed that PKH67 alone at 37°C or PKH67-labeled EVs at 4°C produced no signal, validating active EV import monitoring (Fig. 1C). Using this approach, they observed that both HUVECs and HPaMECs imported PDAC EVs (Fig. 2C-E). Notably, HPaMECs-but not HUVECs-imported significantly fewer HuR-KO EVs than WT EVs, consistent with reports that EV import is a regulated process involving tissue- or cell-specific receptor-ligand interactions. These findings validate previous reports that endothelial cells import PDAC EVs in vitro.

Validation of EV import imaging in vitro.

Fig. 1. Validation of EV import imaging in vitro (Finan JM, Guo Y, et al., 2025).

Endothelial cell abundance correlates with ELAVL1 expression, and endothelial cells import PDAC EVs

Fig. 2. Endothelial cell abundance correlates with ELAVL1 expression, and endothelial cells import PDAC EVs (Finan JM, Guo Y, et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products